23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
2don MSN
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that ...
Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...
Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.
The biotech company 23andMe has a big mess to clean up after its entire board resigned to protest its CEO’s plans to take the ...
Below, we'll break down the best DNA test options on the market so you can find the one that'll work best for you. For the average person looking to dig into their genetics and traits, 23andMe ...
Co-Founder and CEO Anne Wojcicki has failed to offer an actionable plan to take the company private, directors say Shares of DNA-testing company 23andMe Holding Co. tumbled 7% early Wednesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback